Liquidia (NASDAQ:LQDA) Reaches New 52-Week High – Time to Buy?

Shares of Liquidia Corporation (NASDAQ:LQDAGet Free Report) reached a new 52-week high on Wednesday . The company traded as high as $91.36 and last traded at $90.87, with a volume of 122736 shares. The stock had previously closed at $88.38.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a research note on Friday, July 17th. Oppenheimer set a $75.00 price target on Liquidia in a research note on Friday, June 5th. Wells Fargo & Company increased their price target on Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 12th. Wall Street Zen lowered Liquidia from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 27th. Finally, Stephens set a $130.00 price objective on Liquidia in a report on Friday, July 24th. Three equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $86.18.

Read Our Latest Analysis on LQDA

Liquidia Price Performance

The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18. The firm has a market cap of $7.92 billion, a price-to-earnings ratio of 634.44 and a beta of 0.58. The company’s 50-day moving average is $75.88 and its 200-day moving average is $53.44.

Liquidia (NASDAQ:LQDAGet Free Report) last announced its quarterly earnings data on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The business had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. Liquidia’s quarterly revenue was up 4187.1% on a year-over-year basis. Equities research analysts predict that Liquidia Corporation will post 3.02 earnings per share for the current year.

Insiders Place Their Bets

In other Liquidia news, Director Stephen M. Bloch sold 100,000 shares of Liquidia stock in a transaction dated Thursday, July 23rd. The stock was sold at an average price of $89.48, for a total value of $8,948,000.00. Following the transaction, the director owned 501,477 shares in the company, valued at $44,872,161.96. The trade was a 16.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Sanjeev Khindri sold 1,185 shares of the business’s stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $71.51, for a total value of $84,739.35. Following the transaction, the insider directly owned 65,947 shares of the company’s stock, valued at approximately $4,715,869.97. The trade was a 1.77% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 2,150,754 shares of company stock valued at $142,869,858 over the last ninety days. 25.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Covestor Ltd boosted its position in Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after acquiring an additional 359 shares during the last quarter. PNC Financial Services Group Inc. raised its position in shares of Liquidia by 7.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock worth $217,000 after acquiring an additional 422 shares in the last quarter. Quantinno Capital Management LP lifted its stake in shares of Liquidia by 3.6% in the 1st quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock valued at $648,000 after purchasing an additional 589 shares during the period. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Liquidia in the 4th quarter valued at about $25,000. Finally, ProShare Advisors LLC boosted its position in shares of Liquidia by 7.1% during the 4th quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock valued at $405,000 after purchasing an additional 775 shares in the last quarter. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Liquidia Company Profile

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

Recommended Stories

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.